世界の鼻腔内粘膜噴霧装置市場インサイト及び予測(ガス推進式アトマイザー、電子式アトマイザー)

◆英語タイトル:Global Intranasal Mucosal Atomization Device Market Insights, Forecast to 2028

QYResearchが発行した調査報告書(QY22JLX09615)◆商品コード:QY22JLX09615
◆発行会社(リサーチ会社):QYResearch
◆発行日:2022年7月(※2025年版があります。お問い合わせください。)
◆ページ数:93
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥744,800見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,117,200見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,489,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、鼻腔内粘膜噴霧装置のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に鼻腔内粘膜噴霧装置の世界市場のxxx%を占める「ガス推進式アトマイザー」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「病院・クリニック」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
鼻腔内粘膜噴霧装置の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパの鼻腔内粘膜噴霧装置市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

鼻腔内粘膜噴霧装置のグローバル主要企業には、Teleflex、Drive Medical、BD、MILA International、Cook Medical、Medica Holdings、Kurve Technologyなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

鼻腔内粘膜噴霧装置市場は、種類と用途によって区分されます。世界の鼻腔内粘膜噴霧装置市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
ガス推進式アトマイザー、電子式アトマイザー

【用途別セグメント】
病院・クリニック、外来手術センター

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 鼻腔内粘膜噴霧装置製品概要
- 種類別市場(ガス推進式アトマイザー、電子式アトマイザー)
- 用途別市場(病院・クリニック、外来手術センター)
- 調査の目的
・エグゼクティブサマリー
- 世界の鼻腔内粘膜噴霧装置販売量予測2017-2028
- 世界の鼻腔内粘膜噴霧装置売上予測2017-2028
- 鼻腔内粘膜噴霧装置の地域別販売量
- 鼻腔内粘膜噴霧装置の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別鼻腔内粘膜噴霧装置販売量
- 主要メーカー別鼻腔内粘膜噴霧装置売上
- 主要メーカー別鼻腔内粘膜噴霧装置価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(ガス推進式アトマイザー、電子式アトマイザー)
- 鼻腔内粘膜噴霧装置の種類別販売量
- 鼻腔内粘膜噴霧装置の種類別売上
- 鼻腔内粘膜噴霧装置の種類別価格
・用途別市場規模(病院・クリニック、外来手術センター)
- 鼻腔内粘膜噴霧装置の用途別販売量
- 鼻腔内粘膜噴霧装置の用途別売上
- 鼻腔内粘膜噴霧装置の用途別価格
・北米市場
- 北米の鼻腔内粘膜噴霧装置市場規模(種類別、用途別)
- 主要国別の鼻腔内粘膜噴霧装置市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの鼻腔内粘膜噴霧装置市場規模(種類別、用途別)
- 主要国別の鼻腔内粘膜噴霧装置市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の鼻腔内粘膜噴霧装置市場規模(種類別、用途別)
- 主要国別の鼻腔内粘膜噴霧装置市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の鼻腔内粘膜噴霧装置市場規模(種類別、用途別)
- 主要国別の鼻腔内粘膜噴霧装置市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの鼻腔内粘膜噴霧装置市場規模(種類別、用途別)
- 主要国別の鼻腔内粘膜噴霧装置市場規模(トルコ、サウジアラビア)
・企業情報
Teleflex、Drive Medical、BD、MILA International、Cook Medical、Medica Holdings、Kurve Technology
・産業チェーン及び販売チャネル分析
- 鼻腔内粘膜噴霧装置の産業チェーン分析
- 鼻腔内粘膜噴霧装置の原材料
- 鼻腔内粘膜噴霧装置の生産プロセス
- 鼻腔内粘膜噴霧装置の販売及びマーケティング
- 鼻腔内粘膜噴霧装置の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 鼻腔内粘膜噴霧装置の産業動向
- 鼻腔内粘膜噴霧装置のマーケットドライバー
- 鼻腔内粘膜噴霧装置の課題
- 鼻腔内粘膜噴霧装置の阻害要因
・主な調査結果

Market Analysis and Insights: Global Intranasal Mucosal Atomization Device Market
Due to the COVID-19 pandemic, the global Intranasal Mucosal Atomization Device market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Gas Propulsion Atomizer accounting for % of the Intranasal Mucosal Atomization Device global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals and Clinics segment is altered to an % CAGR throughout this forecast period.
China Intranasal Mucosal Atomization Device market size is valued at US$ million in 2021, while the US and Europe Intranasal Mucosal Atomization Device are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Intranasal Mucosal Atomization Device landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Intranasal Mucosal Atomization Device include Teleflex, Drive Medical, BD, MILA International, Cook Medical, Medica Holdings and Kurve Technology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Intranasal Mucosal Atomization Device Scope and Segment
Intranasal Mucosal Atomization Device market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Intranasal Mucosal Atomization Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Gas Propulsion Atomizer
Electronic Atomizer
Segment by Application
Hospitals and Clinics
Ambulatory Surgery Center
By Company
Teleflex
Drive Medical
BD
MILA International
Cook Medical
Medica Holdings
Kurve Technology
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Intranasal Mucosal Atomization Device Product Introduction
1.2 Market by Type
1.2.1 Global Intranasal Mucosal Atomization Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Gas Propulsion Atomizer
1.2.3 Electronic Atomizer
1.3 Market by Application
1.3.1 Global Intranasal Mucosal Atomization Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals and Clinics
1.3.3 Ambulatory Surgery Center
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Intranasal Mucosal Atomization Device Sales Estimates and Forecasts 2017-2028
2.2 Global Intranasal Mucosal Atomization Device Revenue Estimates and Forecasts 2017-2028
2.3 Global Intranasal Mucosal Atomization Device Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Intranasal Mucosal Atomization Device Sales by Region
2.4.1 Global Intranasal Mucosal Atomization Device Sales by Region (2017-2022)
2.4.2 Global Sales Intranasal Mucosal Atomization Device by Region (2023-2028)
2.5 Global Intranasal Mucosal Atomization Device Revenue by Region
2.5.1 Global Intranasal Mucosal Atomization Device Revenue by Region (2017-2022)
2.5.2 Global Intranasal Mucosal Atomization Device Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Intranasal Mucosal Atomization Device Sales by Manufacturers
3.1.1 Global Top Intranasal Mucosal Atomization Device Manufacturers by Sales (2017-2022)
3.1.2 Global Intranasal Mucosal Atomization Device Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Intranasal Mucosal Atomization Device in 2021
3.2 Global Intranasal Mucosal Atomization Device Revenue by Manufacturers
3.2.1 Global Intranasal Mucosal Atomization Device Revenue by Manufacturers (2017-2022)
3.2.2 Global Intranasal Mucosal Atomization Device Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Intranasal Mucosal Atomization Device Revenue in 2021
3.3 Global Intranasal Mucosal Atomization Device Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Intranasal Mucosal Atomization Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Intranasal Mucosal Atomization Device Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Intranasal Mucosal Atomization Device Sales by Type
4.1.1 Global Intranasal Mucosal Atomization Device Historical Sales by Type (2017-2022)
4.1.2 Global Intranasal Mucosal Atomization Device Forecasted Sales by Type (2023-2028)
4.1.3 Global Intranasal Mucosal Atomization Device Sales Market Share by Type (2017-2028)
4.2 Global Intranasal Mucosal Atomization Device Revenue by Type
4.2.1 Global Intranasal Mucosal Atomization Device Historical Revenue by Type (2017-2022)
4.2.2 Global Intranasal Mucosal Atomization Device Forecasted Revenue by Type (2023-2028)
4.2.3 Global Intranasal Mucosal Atomization Device Revenue Market Share by Type (2017-2028)
4.3 Global Intranasal Mucosal Atomization Device Price by Type
4.3.1 Global Intranasal Mucosal Atomization Device Price by Type (2017-2022)
4.3.2 Global Intranasal Mucosal Atomization Device Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Intranasal Mucosal Atomization Device Sales by Application
5.1.1 Global Intranasal Mucosal Atomization Device Historical Sales by Application (2017-2022)
5.1.2 Global Intranasal Mucosal Atomization Device Forecasted Sales by Application (2023-2028)
5.1.3 Global Intranasal Mucosal Atomization Device Sales Market Share by Application (2017-2028)
5.2 Global Intranasal Mucosal Atomization Device Revenue by Application
5.2.1 Global Intranasal Mucosal Atomization Device Historical Revenue by Application (2017-2022)
5.2.2 Global Intranasal Mucosal Atomization Device Forecasted Revenue by Application (2023-2028)
5.2.3 Global Intranasal Mucosal Atomization Device Revenue Market Share by Application (2017-2028)
5.3 Global Intranasal Mucosal Atomization Device Price by Application
5.3.1 Global Intranasal Mucosal Atomization Device Price by Application (2017-2022)
5.3.2 Global Intranasal Mucosal Atomization Device Price Forecast by Application (2023-2028)
6 North America
6.1 North America Intranasal Mucosal Atomization Device Market Size by Type
6.1.1 North America Intranasal Mucosal Atomization Device Sales by Type (2017-2028)
6.1.2 North America Intranasal Mucosal Atomization Device Revenue by Type (2017-2028)
6.2 North America Intranasal Mucosal Atomization Device Market Size by Application
6.2.1 North America Intranasal Mucosal Atomization Device Sales by Application (2017-2028)
6.2.2 North America Intranasal Mucosal Atomization Device Revenue by Application (2017-2028)
6.3 North America Intranasal Mucosal Atomization Device Market Size by Country
6.3.1 North America Intranasal Mucosal Atomization Device Sales by Country (2017-2028)
6.3.2 North America Intranasal Mucosal Atomization Device Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Intranasal Mucosal Atomization Device Market Size by Type
7.1.1 Europe Intranasal Mucosal Atomization Device Sales by Type (2017-2028)
7.1.2 Europe Intranasal Mucosal Atomization Device Revenue by Type (2017-2028)
7.2 Europe Intranasal Mucosal Atomization Device Market Size by Application
7.2.1 Europe Intranasal Mucosal Atomization Device Sales by Application (2017-2028)
7.2.2 Europe Intranasal Mucosal Atomization Device Revenue by Application (2017-2028)
7.3 Europe Intranasal Mucosal Atomization Device Market Size by Country
7.3.1 Europe Intranasal Mucosal Atomization Device Sales by Country (2017-2028)
7.3.2 Europe Intranasal Mucosal Atomization Device Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Intranasal Mucosal Atomization Device Market Size by Type
8.1.1 Asia Pacific Intranasal Mucosal Atomization Device Sales by Type (2017-2028)
8.1.2 Asia Pacific Intranasal Mucosal Atomization Device Revenue by Type (2017-2028)
8.2 Asia Pacific Intranasal Mucosal Atomization Device Market Size by Application
8.2.1 Asia Pacific Intranasal Mucosal Atomization Device Sales by Application (2017-2028)
8.2.2 Asia Pacific Intranasal Mucosal Atomization Device Revenue by Application (2017-2028)
8.3 Asia Pacific Intranasal Mucosal Atomization Device Market Size by Region
8.3.1 Asia Pacific Intranasal Mucosal Atomization Device Sales by Region (2017-2028)
8.3.2 Asia Pacific Intranasal Mucosal Atomization Device Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Intranasal Mucosal Atomization Device Market Size by Type
9.1.1 Latin America Intranasal Mucosal Atomization Device Sales by Type (2017-2028)
9.1.2 Latin America Intranasal Mucosal Atomization Device Revenue by Type (2017-2028)
9.2 Latin America Intranasal Mucosal Atomization Device Market Size by Application
9.2.1 Latin America Intranasal Mucosal Atomization Device Sales by Application (2017-2028)
9.2.2 Latin America Intranasal Mucosal Atomization Device Revenue by Application (2017-2028)
9.3 Latin America Intranasal Mucosal Atomization Device Market Size by Country
9.3.1 Latin America Intranasal Mucosal Atomization Device Sales by Country (2017-2028)
9.3.2 Latin America Intranasal Mucosal Atomization Device Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Intranasal Mucosal Atomization Device Market Size by Type
10.1.1 Middle East and Africa Intranasal Mucosal Atomization Device Sales by Type (2017-2028)
10.1.2 Middle East and Africa Intranasal Mucosal Atomization Device Revenue by Type (2017-2028)
10.2 Middle East and Africa Intranasal Mucosal Atomization Device Market Size by Application
10.2.1 Middle East and Africa Intranasal Mucosal Atomization Device Sales by Application (2017-2028)
10.2.2 Middle East and Africa Intranasal Mucosal Atomization Device Revenue by Application (2017-2028)
10.3 Middle East and Africa Intranasal Mucosal Atomization Device Market Size by Country
10.3.1 Middle East and Africa Intranasal Mucosal Atomization Device Sales by Country (2017-2028)
10.3.2 Middle East and Africa Intranasal Mucosal Atomization Device Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Teleflex
11.1.1 Teleflex Corporation Information
11.1.2 Teleflex Overview
11.1.3 Teleflex Intranasal Mucosal Atomization Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Teleflex Intranasal Mucosal Atomization Device Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Teleflex Recent Developments
11.2 Drive Medical
11.2.1 Drive Medical Corporation Information
11.2.2 Drive Medical Overview
11.2.3 Drive Medical Intranasal Mucosal Atomization Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Drive Medical Intranasal Mucosal Atomization Device Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Drive Medical Recent Developments
11.3 BD
11.3.1 BD Corporation Information
11.3.2 BD Overview
11.3.3 BD Intranasal Mucosal Atomization Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 BD Intranasal Mucosal Atomization Device Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 BD Recent Developments
11.4 MILA International
11.4.1 MILA International Corporation Information
11.4.2 MILA International Overview
11.4.3 MILA International Intranasal Mucosal Atomization Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 MILA International Intranasal Mucosal Atomization Device Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 MILA International Recent Developments
11.5 Cook Medical
11.5.1 Cook Medical Corporation Information
11.5.2 Cook Medical Overview
11.5.3 Cook Medical Intranasal Mucosal Atomization Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Cook Medical Intranasal Mucosal Atomization Device Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Cook Medical Recent Developments
11.6 Medica Holdings
11.6.1 Medica Holdings Corporation Information
11.6.2 Medica Holdings Overview
11.6.3 Medica Holdings Intranasal Mucosal Atomization Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Medica Holdings Intranasal Mucosal Atomization Device Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Medica Holdings Recent Developments
11.7 Kurve Technology
11.7.1 Kurve Technology Corporation Information
11.7.2 Kurve Technology Overview
11.7.3 Kurve Technology Intranasal Mucosal Atomization Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Kurve Technology Intranasal Mucosal Atomization Device Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Kurve Technology Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Intranasal Mucosal Atomization Device Industry Chain Analysis
12.2 Intranasal Mucosal Atomization Device Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Intranasal Mucosal Atomization Device Production Mode & Process
12.4 Intranasal Mucosal Atomization Device Sales and Marketing
12.4.1 Intranasal Mucosal Atomization Device Sales Channels
12.4.2 Intranasal Mucosal Atomization Device Distributors
12.5 Intranasal Mucosal Atomization Device Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Intranasal Mucosal Atomization Device Industry Trends
13.2 Intranasal Mucosal Atomization Device Market Drivers
13.3 Intranasal Mucosal Atomization Device Market Challenges
13.4 Intranasal Mucosal Atomization Device Market Restraints
14 Key Findings in The Global Intranasal Mucosal Atomization Device Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の鼻腔内粘膜噴霧装置市場インサイト及び予測(ガス推進式アトマイザー、電子式アトマイザー)(Global Intranasal Mucosal Atomization Device Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。